Syntax Research, Inc. Alcon Inc Transaction History
Syntax Research, Inc.
- $148 Billion
- Q3 2024
A detailed history of Syntax Research, Inc. transactions in Alcon Inc stock. As of the latest transaction made, Syntax Research, Inc. holds 250 shares of ALC stock, worth $21,575. This represents 0.02% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$21,575
Previous $22.3 Million
12.34%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding ALC
# of Institutions
729Shares Held
242MCall Options Held
2.35MPut Options Held
1.65M-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.67 Billion0.04% of portfolio
-
Credit Suisse Ag Zurich, V815.5MShares$1.33 Billion1.27% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL12MShares$1.04 Billion0.32% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA11.9MShares$1.02 Billion2.3% of portfolio
-
Harding Loevner LP Bridgewater, NJ9.27MShares$800 Million5.43% of portfolio
About ALCON INC
- Ticker ALC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 490,087,008
- Market Cap $42.3B
- Description
- Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...